SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-14-253322
Filing Date
2014-06-27
Accepted
2014-06-27 16:14:42
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d746704d424b5.htm 424B5 442063
2 GRAPHIC g746704g04u33.jpg GRAPHIC 16549
3 GRAPHIC g746704g27m14.jpg GRAPHIC 6800
4 GRAPHIC g746704g76i05.jpg GRAPHIC 4035
5 GRAPHIC g746704g85x88.jpg GRAPHIC 20776
  Complete submission text file 0001193125-14-253322.txt   510076
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-184829 | Film No.: 14946141
SIC: 2835 In Vitro & In Vivo Diagnostic Substances